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INTRODUCTION
The first closure of patent ductus arteriosus (PDA) was
reported by Porstmann et al. (1) in 1971. Thereafter, several
different devices have been used in the interventional occlu-
sion of a PDA, and have produces varying degrees of success.
Gianturco embolization coils and Cook detachable coils (Cook
Cardiology, Bloomington, IN, U.S.A.) have proven both safe
and effective in the closure of small- to moderate sized PDA
(2-4). However, they have not been shown to be effective in
the closure of large PDA. For the transcatheter closure of
moderate to large PDA, the Amplatzer ductal occluder (ADO)
device (AGA Medical Corporation, Golden Valley, Minnesota,
U.S.A.) and the Nit-Occlud (Pfm, Cologne, Germany) device
have been developed, and have met with relatively favorable
outcomes (5, 6).
However, some complications have still been reported to
occur after the transcatheter closure of PDA (7, 8). In the
present report, we described the short- and mid-term results
and complications we encountered after the interventional
occlusion of a PDA with a minimum diameter of more than
3 mm, using different devices.
MATERIALS AND METHODS
Patients
Between October 1999 and December 2005, 117 patients
(34 males, 83 females) with PDA, with a minimum diameter
of more than 3 mm, underwent transcatheter PDA closure
procedures (Fig. 1). Informed consent was obtained from all
patients prior to performance of the procedures. The median
age of the 117 patients at catheterization was 11 yr (range,
0.6 to 68 yr), and the median weight was 30 kg (range, 6 to
74 kg). We included patients with PDA, with a minimum
diameter of more than 3 mm as evidenced by an angiogram. 
Devices and procedures
The interventional procedure was conducted under local
anesthesia. All patients received prophylactic antibiotic ther-
apy prior to catheterization. After the percutaneous puncture
of the femoral vein and artery, all hemodynamic variables were
evaluated. The shape and size of the PDA were then assessed
via an aortogram, from the right anterior oblique and lateral
projections. The ductal shape was classified in accordance with
the classifications established by Krichenko et al. (9). On the
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Complications after Transcatheter Closure of Patent Ductus Arteriosus
To evaluate the short- and mid-term results and complications ensuing the tran-
scatheter closure of patent ductus arteriosus (PDA). Between October 1999 and
December 2005, 117 patients (34 males and 83 females) underwent attempted
percutaneous closure of PDA with a minimum diameter of more than 3 mm. Fol-
low-up evaluations were conducted at 1 day and 1, 3, 6, 12 months after the per-
formance of the transcatheter closure. The median age of patients at catheteriza-
tion was 11 yr (range, 0.6 to 68 yr), median weight was 30 kg (range, 6 to 74 kg),
and the median diameter of PDA was 4 mm (range, 3 to 8 mm). This procedure
was conducted successfully in 114 patients (97.4%), using different devices. Major
complications were detected in 4 patients (3.4%); significant hemolysis (2), infec-
tive endocarditis (1), failed procedure due to embolization (1). Minor complications
occurred in 6 patients (5.1%); mild narrowing of the descending aorta (2) and mild
encroachment on the origin of the left pulmonary artery (4). Although the transca-
theter closure of PDA may be considered to be effective, several complications,
including hemolysis, embolization, infective endocarditis, and the narrowing of adja-
cent vessels may occur in certain cases.
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basis of ductal morphology and size, interventional occlusions
were conducted with ADO (97 patients), Cook detachable
coil (15 patients), Nit-Occlud coil (4 patients), or a buttoned
device combined with a Cook detachable coil (1 patient). The
ADO device used was 1-2 mm larger than the narrowest
diameter of the PDA, and was implanted via a venous app-
roach. In the usage of the Nit-Occlud coils, we selected coils
on the basis of the following criteria; the largest device loop
diameter was equal to the aortic ampulla and was 3-4 mm
larger than the narrowest duct diameter, and was deployed
via the venous approach. In the multiple detachable coils
approach, the first coil used was approximately 2.5 times
larger than the narrowest diameter of the PDA, and the sec-
ond coil used was 1.5 to 2.0 times larger than the narrowest
diameter. 
Follow-up
Transthoracic echocardiographic evaluations and chest radio-
graphy were conducted on all patients prior to discharge, and
at 1, 3, 6, 12 months after the procedure. Follow-up evalua-
tions at 12 months were not perfomed yet in a few patients
due to the short-term follow-up period. Special attention was
paid to the residual PDA flow and protrusion of the device
into the left pulmonary artery or into the descending aorta.
RESULTS
The transcatheter closure was conducted successfully in
114 (97.4%) out of 117 patients, using different devices in-
cluding the ADO, Nit-Occlud coil, and Cook detachable
coils. The median fluoroscopy time for PDA closure was 16
minutes (range, 3 to 40 min), median pulmonary artery mean
pressure was 26 mmHg (range, 13 to 66 mmHg), and the
median Qp/Qs ratio (pulmonary/systemic flow ratio) was 1.9
(range 1.1 to 4.8). According to the classifications established
by Krichenko et al., the PDA assumed a conical shape in 95
patients (81.1%), a tubular shape in 15 patients (12.8%), and
a window-like morphology in 7 patients (5.9%). The median
value of the narrowest PDA diameter, as determined by aor-
tography, was 4 mm (range 3 to 8 mm). The echocardiogra-
phic examinations showed that complete PDA occlusion was
achieved in 79.5% of patients at 24 hr, 89.7% at 1 month,
96% 1 yr after the procedure, and 4 patients (3.4%) were shown
to have a small residual shunt at the 1 yr follow-up. 
Major complications were noted in 4 patients (3.4%). Two
patients showed significant hemolysis due to residual leakage,
infective endocarditis was suspected in one patient, and sur-
gical closure due to embolization was observed in one patient.
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Fig. 1. Distribution of cases by year.
Major complications
Significant hemolysis 2
Infective endocarditis 1
Device embolization requiring surgery 1
Total events 4 (3.4%)
Minor complications
Mild narrowing of left pulmonary artery 4
Mild narrowing of descending aorta 2
Total events 6 (5.1%)
Table 1. Procedural complications (n=117)
No Age (yr)
PDA size 
(mm)
Type  Qp/Qs FT (min) Complica-
tions
Results Size (mm)   
Device
type 
Weight (kg)
1 2.1 11.5 3.5 Co 1.9 DC 6.5 SS H 18
2 12 26 5.2 Co 2.1 BD 25 SS H 30
DC 6.5
3 1.2 9.7 3.9 Co 2.8 DC 6.5 SS E 19
4 7.7 18 8 Co 3.0 ADO 12/10 C IE 25
5 0.6 6.9 5 Co 2.5 ADO 10/8 C Ao, LPA 10
6 0.5 6 3.9 T 3.0 ADO 8/6 C Ao 12
7 5.1 17 6.2 T 2.0 ADO 10/8 TS LPA 13
8 8.7 24 3.3 T 1.3 MDC 8, 6.5 TS LPA 19
9 1.7 10 3 T 1.6 MDC 6.5, 5 C LPA 33 
Table 2. Clinical data of patients who developed complications
ADO, Amplatzer ductal occluder; Ao, aortic narrowing; BD, buttoned device; C, closure; Co, conical type; DC, Cook detachable coil; E, embolization;
FT, fluoroscopy time; H, hemolysis; LPA, narrowing of left pulmonary artery; MDC, multiple detachable coils; Qp/Qs, pulmonary/systemic flow ratio; SS,
significant residual shunt; T, tubular type; TS, trace shunt; 5, 5 mm×5 loops; 6.5, 6.5 mm×5 loops; 8, 8 mm×5 loops.486 G.Y. Jang, C.S. Son, J.W. Lee, et al.
Minor complications were observed in 6 patients (5.1%):
mild stenosis of the left pulmonary artery via device encroach-
ment was detected in 4 patients, and a mild narrowing of
the descending aorta was seen in 2 patients (Table 1, 2). 
Hemolysis
Two patients developed hemolysis during the study period.
In one patient (No 2 in Table 2), a 12-yr-old male, the ductal
size was measured at 5.2 mm, and the Qp/Qs ratio was 2.1.
The buttoned device was initially implanted for the closure
of the PDA. After device occlusion, the patient exhibited
significant residual flow, and thereafter, a second transcatheter
closure was conducted using a Cook detachable coil (0.038’’,
6.5 mm×5-loops) to close the residual leak. After the per-
formance of a coil occlusion, however, a significant residual
jet was observed. Thereafter, urine discoloration was noticed
12 hr after the procedure, hemoglobin levels fell from 13.8
g/dL to 11.5 g/dL, and the patient’s direct bilirubin count
was elevated, at 2.1 mg/dL. This patient was sent to the oper-
ating room in order to deal with significant hemolysis. After
the removal of the device, PDA ligation was conducted. In
the other patient (No 1 in Table 2), a 2-yr old male, the PDA
size was 3.5 mm with a systolic pulmonary artery pressure of
26 mmHg, and a Cook detachable coil (0.038’’, 6.5 mm×
4-loops) was initially deployed in an inappropriate position
with a small amount of residual flow. However, significant
residual shunts were observed on echocardiographic examina-
tion after the procedure, and slight migration of the coil in
ductus was suspected. With regard to our laboratory find-
ings, the patient’s hemoglobin levels fell to 8.5 g/dL. After
blood transfusion, the patient was sent to the catheterization
laboratory, where the malpositioned coil was retrieved, and
another Cook detachable coil (0.038’’, 6.5 mm×5-loops) was
re-deployed. In the post-deployment aortography, only a triv-
ial amount of residual flow was observed. After the second
procedure, the patient’s general condition and laboratory
parameters gradually improved.
Infective endocarditis
Infective endocarditis was suspected in one case (No 4 in
Table 2), a 7-yr-old female with an 8 mm duct with a systolic
pulmonary artery pressure of 57 mmHg. Her PDA was closed
using a 12/10 mm ADO. Immediate post-deployment angio-
graphy revealed trivial residual flow through the device (Fig.
2). At the time of admission, the patient was afebrile, and
there were no abnormal laboratory findings. However, 1 day
after the procedure, the patient appeared febrile and the fever
persisted for 3 days, and then subsided for 4 consecutive days.
Thereafter, high-grade fever redeveloped and persisted for
approximately 30 days despite the proper usage of adequate
antibiotics. Laboratory examination revealed a white blood
cell count of 14,900 mg/dL, a hemoglobin concentration of
11.4 g/dL, and a C-reactive protein concentration of 7.01 mg/
dL. Although serial blood cultures were acquired from the
patient, we isolated no organisms. Upon echocardiographic
examination, no vegetation was present. We were unable to
locate the cause of fever, with the exception of the possibility
of infective endocarditis via device implantation. Therefore,
we decided to operate on this patient for the removal of the
device and for PDA ligation. After the ADO had been surgi-
cally removed and the PDA ligated, the patient eventually
achieved a full recovery.
Fig. 2. (A) Lateral aortogram showing a patent ductus arteriosus, 8 mm in diameter. (B) Lateral aortogram after implantation of a 12/10 mm
Amplatzer ductal occluder showing trivial residual flow in the pulmonary artery.
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Device embolization 
This case (No 3 in Table 2) involved a 14-month-old boy
with a 3.9 mm duct, with a systolic pulmonary artery pres-
sure of 28 mmHg. A Cook detachable coil (0.038’’, 6.5 mm
×5-loops) was deployed in this case. However, the device em-
bolized to the left pulmonary artery after a few minutes, and
the coil was percutaneously retrieved. The patient was then
referred for surgical ligation, as no other PDA devices, such
as an ADO or Nit-Occlud coil, were available at the time.
Narrowing of descending aorta and pulmonary artery
In two patients, after the implantation of the ADO, the
device was seen to protrude into the descending aorta, result-
ing in a peak velocity of 2 m/sec on Doppler echocardiogra-
phy in one patient (No 6 in Table 2) and a peak velocity of
2.2 m/sec in the other patient (No 5, Fig. 3). The pressure
gradient across the aortic isthmus was 2-4 mmHg in the
catheterization laboratory in these two patients. One of the
patients was 6 month-old, and the other was 7 month-old.
Both patients weighed less than 7 kg. In 4 patients (No 5,
7-9 in Table 2), after the procedure, device encroachment
Fig. 3. Aortogram in lateral (A) and right anterior oblique view (B) displaying a large patent ductus arteriosus, 5 mm in diameter. Aortograms
in lateral (C) and right anterior oblique view (D) after implantation of a 10/8 mm Amplatzer ductal oceluder show the protrusion of the retention
disc into the aortic lumen. 
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was observed on the origin of the left pulmonary artery, result-
ing in abnormal flow at a peak velocity of 2-2.5 m/sec. In one
of these patients, we observed a partial obstruction of the left
pulmonary artery. This was a 7-month-old patient (No 5 in
Table 2) with a 5 mm duct, with a systolic pulmonary artery
pressure of 79 mmHg, and the PDA of this patient was closed
using a 10/8 mm ADO. After the deployment of the ADO,
the device was observed to protrude into the descending aorta,
thereby resulting in a mild narrowing of the descending aorta
with no significant pressure gradient in the catheterization
laboratory. After the procedure, on the echocardiogram, device
encroachment was observed on the origin of the left pulmo-
nary artery, resulting in a peak velocity of 2.5 m/sec. In the
lung perfusion scan, a diffusely decreased perfusion of the left
lung was observed, with a quantitative lung perfusion scan
evidencing a 39% flow to the left lung (Fig. 4). However,
after the procedure, heart failure symptoms improved and
the patient was discharged 2 days later. On the echocardio-
gram at 12 months after transcatheter closure of PDA, nar-
rowing of descending aorta and left pulmonary artery was
re-evaluated. Although the device was seen to protrude into
descending aorta and left pulmonary artery, the peak veloci-
ty by Doppler echocardiography in descending aorta decre-
ased from 2.2 m/sec to 1.6 m/sec (Fig. 5), and the peak veloc-
ity in left pulmonary artery decreased from 2.5 m/sec to 1.7
m/sec. In the other 3 patients, although device encroachment
was also observed on the origin of the left pulmonary artery,
no significant obstructions were noted to exist. On follow-
up Dopper echocardiography, there was no significant pres-
sure gradient in left pulmonary artery in these patients.
DISCUSSION
Interventional PDA occlusion is an established and effec-
tive procedure, and a variety of devices have been introduced
into clinical practice (10-14). Masura et al. (15) described the
use of the ADO in the occlusion of moderate to large PDA.
Thereafter, numerous clinical experiences with the transca-
theter closure of moderate to large PDAs have been reported
(8, 13, 15). Although the results of interventional occlusion
have been generally satisfactory, some complications have been
reported to occur after transcatheter PDA closure procedures.
According to the report of Faella and Hijazi (7), 15 (4.7%)
of 316 patients experienced complications, including one
each patient with sudden death after procedure, hemolysis,
Fig. 4. A quantitative lung perfusion scan after deployment of a
10/8 mm ADO shows a decreased perfusion of the left lung. ANT,
anterior.
ANT
Fig. 5. (A) Transthoracic echocardiography shows the protrusion of the device (arrow) into the aortic lumen. (B) Doppler echocardiogra-
phy in descending aorta shows a peak velocity of 1.6 m/sec.
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transient asystole, ST depression due to blood loss, surgical
closure due to device embolization, malpositioning of the
device, and blood transfusion due to blood loss, and 8 patients
with other, minor complications.
In our study, 4 major complications (3.4%) and 6 minor
complications (5.1%) were encountered among 117 patients
with PDA, with a minimum diameter of more than 3 mm.
In 2 patients, significant hemolysis was noted after transca-
theter PDA closure, as a result of significant residual shunt.
In previous reports, several investigators have reported hemo-
lysis, device embolization, infection, and significant narrow-
ing of the left pulmonary artery or the descending aorta as
major complications (8, 13, 16). Significant hemolysis after
device deployment is primarily related to residual shunts,
and occurs only rarely. This is believed to result from mechan-
ical injury to the red blood cells, and the severe hemolysis
appeared to have been associated with renal failure and coag-
ulopathy. The reported rate of hemolysis varies, between 0%
to 3.5% (13, 17). The usual management of hemolysis in-
volves the closure of the residual shunt, either surgically or
via the deployment of the appropriate device. In our series
of procedures, significant hemolysis was noted in 2 patients.
In one of these patients, re-intervention was required, and
residual shunts were eliminated after the deployment of the
second device. In the other patient, hemolysis remained un-
controlled after re-intervention, and thus the patient was treat-
ed surgically. 
Device embolization sometimes occurs, necessitating per-
cutaneous retrieval or surgical removal. Device embolization
has been identified as one of the most significant complica-
tions of interventional PDA occlusion (18-20). The report-
ed embolization rate varies, between 0% to 16% (6, 10, 19).
In an effort to decrease the embolization rate and determine
the optimal position, it is necessary to reposition and rede-
ploy the device. As noted earlier, one device embolization
was observed among the present study group. This device
was embolized into the left pulmonary artery, and percuta-
neously retrieved. At that time, other devices, such as the
ADO, were not available, and the patient was thus surgical-
ly managed.
Transcatheter occlusion of large PDA using ADO has been
proved highly efficacious in large series (5, 13). Therefore, our
treatment option of choice for large PDA occlusion involves
the ADO. However, the implantation of the ADO is quite
problematic in infants weighing less than 5 kg (21). From
the perspective of large PDA closure in infants using ADO,
the biggest concern regarding morbidity in relation to this
device would be significant obstruction of the descending
aorta and left pulmonary artery. Although the ADO may
feasibly be deployed in infants with large PDA, the retention
skirt may, in some cases, induce a narrowing of the aorta.
Therefore, the aortic pressure gradient should be constantly
monitored in the catheterization laboratory. In cases in which
the ADO encroaches on the aortic lumen with a significant
pressure gradient, it is recommended that the device be re-
moved. In this study, after the deployment of the ADO, mild
aortic narrowing without significant pressure gradient was
observed in two of the patients. Both patients were infants of
less than 7 kg. On follow-up echocardiography at 12 months,
the peak velocity in descending aorta decreased, as noted ear-
lier. So, we speculate that this type of narrowing of aorta is
expected to disappear gradually with subsequent growth of
the child. The encroachment of the device on the origin of
the left pulmonary artery was observed in four patients. How-
ever, in none of the patients the peak flow velocity of >2.5
m/sec was observed by Doppler echocardiography. Although
the encroachment of the device on the origin of the left pul-
monary artery is of little concern with regard to the redistri-
bution of blood flow, and is expected to lose its significance
with subsequent somatic growth, careful follow-up with
echocardiogram is necessary, especially in infants. In order
to avoid complications such as aortic narrowing in infants
with large PDA, the subsequent development of a modified
ADO retention disk will also be necessary (22, 23).
Infective endocarditis after the implantation of the device
is a rare complication. We could not find any reports regard-
ing infective endocarditis after transcatheter PDA closure. In
our series, one patient developed a high-grade fever for app-
roximately 30 days after ADO implantation. We were unable
to reveal the cause of fever in that patient, with the exception
of infective endocarditis. After the device had been surgical-
ly removed, and the PDA ligation had been completed, the
patient eventually achieved a full recovery. In this patient,
another possibility as a cause of fever would be the nickel
hypersensitivity to the ADO. Some authors reported nickel
hypersensitivity after implantation of a nitinol-containing
device (24, 25). According to their reports (24), high-grade
fever and edema persisted after deployment of the PFO occ-
luder (PFO star; Cardia, Burnsville, MN, U.S.A.). The pati-
ent’s symptoms had persisted until the device was explanted
surgically. In our patient, we did not consider nickel hyper-
sensitivity as a cause of fever at that time. So, we did not carry
out the test for possible nickel hypersensitivity. Although the
risk of a significant hypersensitivity reaction to the nickel
compound in ADO is small, nickel hypersensitivity should
be considered before implantation of these devices.
In conclusion, percutaneous closure of PDA can be conduct-
ed successfully in the majority of patients, including symp-
tomatic infants. This constitutes an alternative option prior
to surgical treatment. However, some complications, includ-
ing significant hemolysis, device embolization, important
left pulmonary artery stenosis, iatrogenic coarctation, infec-
tive endocarditis, and nickel hypersensitivity may be observed
in some cases. In order to minimize these complications, it
is vitally important to select the appropriate device, depend-
ing on the ductal morphology and narrowest diameter, the
size of the descending aorta, and the age and weight of the
patient. Careful clinical evaluations and longer follow-up are490 G.Y. Jang, C.S. Son, J.W. Lee, et al.
also necessary. Further research into the next generation of
such devices will be required in order to develop a more reli-
able and less problematic approach to the transcatheter clo-
sure of a large PDA in small infants.
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